Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, it offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, the company provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation device; suprapubic catheterization products; LIBERTY, a urinary incontinence treatment and control system; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; BioPharm HP-PRT; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health center in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.…
Utah Medical Products, Inc. Increases Quarterly Dividend
Utah Medical Products (NASDAQ: UTMD) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 140 employees.
The shares were at 69.49 USD on 20 November 2026, up 22.3% over 52 weeks. Its 52-week range is 53.66 USD to 76.89 USD: the price is 9.6% below the high and 29.5% above the low.
At a market capitalisation of 198.01M USD, it trades at 20.8 times trailing earnings. The median trailing P/E of its 19 largest Medical Instruments & Supplies peers is 48.3, a discount of 57% for UTMD. It pays a dividend yielding 1.77% (it pays out 37% of its earnings), against a median of 0.92% among the dividend payers in that peer group.
Utah Medical Products reports return on equity of 9.5%, an operating margin of 34.3% and revenue down 12.1% year over year.
It holds more cash than debt, a net cash position of 85.02M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. The next earnings report is expected on 28 January 2027.